Asymmetric Unit(hide GO term definitions)
Chain A,D ( 1A24_HUMAN | P05534)
| molecular function |
|---|
| | GO:0046977 | | TAP binding | | Interacting selectively and non-covalently with TAP protein, transporter associated with antigen processing protein. TAP protein is a heterodimeric peptide transporter consisting of the subunits TAP1 and TAP2. |
| | GO:0030881 | | beta-2-microglobulin binding | | Interacting selectively and non-covalently with beta-2-microglobulin. |
| | GO:0042605 | | peptide antigen binding | | Interacting selectively and non-covalently with an antigen peptide. |
| biological process |
|---|
| | GO:0019882 | | antigen processing and presentation | | The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex. |
| | GO:0002479 | | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | | The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules. |
| | GO:0002480 | | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent | | The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules. |
| | GO:0002474 | | antigen processing and presentation of peptide antigen via MHC class I | | The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules. |
| | GO:0006955 | | immune response | | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| | GO:0002376 | | immune system process | | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
| | GO:0060333 | | interferon-gamma-mediated signaling pathway | | A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far. |
| | GO:0042270 | | protection from natural killer cell mediated cytotoxicity | | The process of protecting a cell from natural killer cell mediated cytotoxicity. |
| | GO:0050776 | | regulation of immune response | | Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. |
| | GO:0060337 | | type I interferon signaling pathway | | A series of molecular signals initiated by the binding of a type I interferon to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families. |
| | GO:0016032 | | viral process | | A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle. |
| cellular component |
|---|
| | GO:0012507 | | ER to Golgi transport vesicle membrane | | The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi. |
| | GO:0005794 | | Golgi apparatus | | A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions. |
| | GO:0000139 | | Golgi membrane | | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
| | GO:0042612 | | MHC class I protein complex | | A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules. |
| | GO:0009986 | | cell surface | | The external part of the cell wall and/or plasma membrane. |
| | GO:0031901 | | early endosome membrane | | The lipid bilayer surrounding an early endosome. |
| | GO:0005783 | | endoplasmic reticulum | | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0071556 | | integral component of lumenal side of endoplasmic reticulum membrane | | The component of the endoplasmic reticulum membrane consisting of the gene products that penetrate only the lumenal side of the membrane. |
| | GO:0016021 | | integral component of membrane | | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0030670 | | phagocytic vesicle membrane | | The lipid bilayer surrounding a phagocytic vesicle. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
Chain B,E ( B2MG_HUMAN | P61769)
| molecular function |
|---|
| | GO:0042802 | | identical protein binding | | Interacting selectively and non-covalently with an identical protein or proteins. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| biological process |
|---|
| | GO:0033077 | | T cell differentiation in thymus | | The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway dependent upon transit through the thymus. |
| | GO:0019731 | | antibacterial humoral response | | An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster. |
| | GO:0019885 | | antigen processing and presentation of endogenous peptide antigen via MHC class I | | The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules. |
| | GO:0002479 | | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | | The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules. |
| | GO:0002480 | | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent | | The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules. |
| | GO:0002481 | | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent | | The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family. |
| | GO:0002474 | | antigen processing and presentation of peptide antigen via MHC class I | | The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules. |
| | GO:0044267 | | cellular protein metabolic process | | The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification. |
| | GO:0071281 | | cellular response to iron ion | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus. |
| | GO:0071222 | | cellular response to lipopolysaccharide | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
| | GO:0050829 | | defense response to Gram-negative bacterium | | Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism. |
| | GO:0050830 | | defense response to Gram-positive bacterium | | Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism. |
| | GO:0006955 | | immune response | | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| | GO:0002376 | | immune system process | | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
| | GO:0045087 | | innate immune response | | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
| | GO:0060333 | | interferon-gamma-mediated signaling pathway | | A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far. |
| | GO:0055072 | | iron ion homeostasis | | Any process involved in the maintenance of an internal steady state of iron ions within an organism or cell. |
| | GO:0010977 | | negative regulation of neuron projection development | | Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
| | GO:1900121 | | negative regulation of receptor binding | | Any process that stops, prevents or reduces the frequency, rate or extent of a protein or other molecule binding to a receptor. |
| | GO:0002726 | | positive regulation of T cell cytokine production | | Any process that activates or increases the frequency, rate, or extent of T cell cytokine production. |
| | GO:0001916 | | positive regulation of T cell mediated cytotoxicity | | Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity. |
| | GO:1904434 | | positive regulation of ferrous iron binding | | Any process that activates or increases the frequency, rate or extent of ferrous iron binding. |
| | GO:0032092 | | positive regulation of protein binding | | Any process that activates or increases the frequency, rate or extent of protein binding. |
| | GO:1900122 | | positive regulation of receptor binding | | Any process that activates or increases the frequency, rate or extent of a protein or other molecule binding to a receptor. |
| | GO:0048260 | | positive regulation of receptor-mediated endocytosis | | Any process that activates or increases the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport. |
| | GO:1904437 | | positive regulation of transferrin receptor binding | | Any process that activates or increases the frequency, rate or extent of transferrin receptor binding. |
| | GO:0042026 | | protein refolding | | The process carried out by a cell that restores the biological activity of an unfolded or misfolded protein, using helper proteins such as chaperones. |
| | GO:0050690 | | regulation of defense response to virus by virus | | Any viral process that modulates the frequency, rate, or extent of the antiviral response of the host cell or organism. |
| | GO:0050776 | | regulation of immune response | | Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. |
| | GO:0003254 | | regulation of membrane depolarization | | Any process that modulates the rate, frequency or extent of membrane depolarization. Membrane depolarization is the process in which membrane potential changes in the depolarizing direction from the resting potential, usually from negative to positive. |
| | GO:0046686 | | response to cadmium ion | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus. |
| | GO:0042493 | | response to drug | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
| | GO:0002237 | | response to molecule of bacterial origin | | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin. |
| | GO:0001895 | | retina homeostasis | | A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function. |
| cellular component |
|---|
| | GO:0012507 | | ER to Golgi transport vesicle membrane | | The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi. |
| | GO:0005794 | | Golgi apparatus | | A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions. |
| | GO:0000139 | | Golgi membrane | | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
| | GO:1990712 | | HFE-transferrin receptor complex | | A protein complex containing at least HFE and a transferrin receptor (either TFR1/TFRC or TFR2), proposed to play a role in the sensing of transferrin-bound Fe (Fe2-Tf) on the plasma membrane to regulate hepcidin transcription. |
| | GO:0042612 | | MHC class I protein complex | | A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0031905 | | early endosome lumen | | The volume enclosed by the membrane of an early endosome. |
| | GO:0031901 | | early endosome membrane | | The lipid bilayer surrounding an early endosome. |
| | GO:0005788 | | endoplasmic reticulum lumen | | The volume enclosed by the membranes of the endoplasmic reticulum. |
| | GO:0009897 | | external side of plasma membrane | | The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| | GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| | GO:0005925 | | focal adhesion | | Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0030670 | | phagocytic vesicle membrane | | The lipid bilayer surrounding a phagocytic vesicle. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
Chain C,F ( TERT_HUMAN | O14746)
| molecular function |
|---|
| | GO:0003677 | | DNA binding | | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
| | GO:0003723 | | RNA binding | | Interacting selectively and non-covalently with an RNA molecule or a portion thereof. |
| | GO:0003968 | | RNA-directed 5'-3' RNA polymerase activity | | Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1); uses an RNA template, i.e. the catalysis of RNA-template-directed extension of the 3'-end of an RNA strand by one nucleotide at a time. |
| | GO:0003964 | | RNA-directed DNA polymerase activity | | Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Catalyzes RNA-template-directed extension of the 3'- end of a DNA strand by one deoxynucleotide at a time. |
| | GO:0046872 | | metal ion binding | | Interacting selectively and non-covalently with any metal ion. |
| | GO:0016779 | | nucleotidyltransferase activity | | Catalysis of the transfer of a nucleotidyl group to a reactant. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0042803 | | protein homodimerization activity | | Interacting selectively and non-covalently with an identical protein to form a homodimer. |
| | GO:0000049 | | tRNA binding | | Interacting selectively and non-covalently with transfer RNA. |
| | GO:0070034 | | telomerase RNA binding | | Interacting selectively and non-covalently with the telomerase RNA template. |
| | GO:0003721 | | telomerase RNA reverse transcriptase activity | | Catalysis of the extension of the 3' end of a DNA strand by one deoxynucleotide at a time. Cannot initiate a chain de novo; uses the RNA subunit of the telomerase enzyme complex as its template. |
| | GO:0003720 | | telomerase activity | | Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Catalyzes extension of the 3'- end of a DNA strand by one deoxynucleotide at a time using an internal RNA template that encodes the telomeric repeat sequence. |
| | GO:0042162 | | telomeric DNA binding | | Interacting selectively and non-covalently with a telomere, a specific structure at the end of a linear chromosome required for the integrity and maintenance of the end. |
| | GO:0001223 | | transcription coactivator binding | | Interacting selectively and non-covalently with a transcription coactivator, any protein involved in positive regulation of transcription via protein-protein interactions with transcription factors and other proteins that positively regulate transcription. Transcription coactivators do not bind DNA directly, but rather mediate protein-protein interactions between activating transcription factors and the basal transcription machinery. |
| | GO:0016740 | | transferase activity | | Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2. |
| biological process |
|---|
| | GO:0071897 | | DNA biosynthetic process | | The cellular DNA metabolic process resulting in the formation of DNA, deoxyribonucleic acid, one of the two main types of nucleic acid, consisting of a long unbranched macromolecule formed from one or two strands of linked deoxyribonucleotides, the 3'-phosphate group of each constituent deoxyribonucleotide being joined in 3',5'-phosphodiester linkage to the 5'-hydroxyl group of the deoxyribose moiety of the next one. |
| | GO:0022616 | | DNA strand elongation | | The DNA metabolic process in which a DNA strand is synthesized by adding nucleotides to the 3' end of an existing DNA stand. |
| | GO:0032774 | | RNA biosynthetic process | | The chemical reactions and pathways resulting in the formation of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage. Includes polymerization of ribonucleotide monomers. Refers not only to transcription but also to e.g. viral RNA replication. |
| | GO:0006278 | | RNA-dependent DNA biosynthetic process | | A DNA biosynthetic process that uses RNA as a template for RNA-dependent DNA polymerases (e.g. reverse transcriptase) that synthesize the new strand. |
| | GO:1904837 | | beta-catenin-TCF complex assembly | | The aggregation, arrangement and bonding together of a set of components to form a beta-catenin-TCF complex. |
| | GO:0071456 | | cellular response to hypoxia | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
| | GO:0070200 | | establishment of protein localization to telomere | | The directed movement of a protein to a specific location in the telomeric region of a chromosome. |
| | GO:0007005 | | mitochondrion organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a mitochondrion; includes mitochondrial morphogenesis and distribution, and replication of the mitochondrial genome as well as synthesis of new mitochondrial components. |
| | GO:2000773 | | negative regulation of cellular senescence | | Any process that stops, prevents or reduces the frequency, rate or extent of cellular senescence. |
| | GO:2001240 | | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. |
| | GO:0010629 | | negative regulation of gene expression | | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| | GO:1903704 | | negative regulation of production of siRNA involved in RNA interference | | Any process that stops, prevents or reduces the frequency, rate or extent of production of siRNA involved in RNA interference. |
| | GO:0030177 | | positive regulation of Wnt signaling pathway | | Any process that activates or increases the frequency, rate or extent of Wnt signal transduction. |
| | GO:0042635 | | positive regulation of hair cycle | | Any process that activates or increases the frequency, rate or extent of the cyclical phases of growth (anagen), regression (catagen), quiescence (telogen), and shedding (exogen) in the life of a hair. |
| | GO:0051000 | | positive regulation of nitric-oxide synthase activity | | Any process that activates or increases the activity of the enzyme nitric-oxide synthase. |
| | GO:1902895 | | positive regulation of pri-miRNA transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription from RNA polymerase II promoter. |
| | GO:0032092 | | positive regulation of protein binding | | Any process that activates or increases the frequency, rate or extent of protein binding. |
| | GO:1904751 | | positive regulation of protein localization to nucleolus | | Any process that activates or increases the frequency, rate or extent of protein localization to nucleolus. |
| | GO:2000648 | | positive regulation of stem cell proliferation | | Any process that activates or increases the frequency, rate or extent of stem cell proliferation. |
| | GO:0030422 | | production of siRNA involved in RNA interference | | Cleavage of double-stranded RNA to form small interfering RNA molecules (siRNAs) of 21-23 nucleotides, in the context of RNA interference. |
| | GO:0031647 | | regulation of protein stability | | Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation. |
| | GO:0090399 | | replicative senescence | | A cell aging process associated with the dismantling of a cell as a response to telomere shortening and/or cellular aging. |
| | GO:0000723 | | telomere maintenance | | Any process that contributes to the maintenance of proper telomeric length and structure by affecting and monitoring the activity of telomeric proteins, the length of telomeric DNA and the replication and repair of the DNA. These processes includes those that shorten, lengthen, replicate and repair the telomeric DNA sequences. |
| | GO:0007004 | | telomere maintenance via telomerase | | The maintenance of proper telomeric length by the addition of telomeric repeats by telomerase. |
| | GO:0001172 | | transcription, RNA-templated | | The cellular synthesis of RNA on a template of RNA. |
| cellular component |
|---|
| | GO:0016605 | | PML body | | A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection. |
| | GO:0031379 | | RNA-directed RNA polymerase complex | | A protein complex that possesses RNA-directed RNA polymerase activity. |
| | GO:1990572 | | TERT-RMRP complex | | A ribonucleoprotein complex that has RNA-directed RNA polymerase (RdRP) activity, and is composed of telomerase reverse transcriptase (TERT) and the non-coding RNA component of mitochondrial RNA processing endoribonuclease (RMRP). |
| | GO:0005694 | | chromosome | | A structure composed of a very long molecule of DNA and associated proteins (e.g. histones) that carries hereditary information. |
| | GO:0000781 | | chromosome, telomeric region | | The terminal region of a linear chromosome that includes the telomeric DNA repeats and associated proteins. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0030529 | | intracellular ribonucleoprotein complex | | An intracellular macromolecular complex containing both protein and RNA molecules. |
| | GO:0042645 | | mitochondrial nucleoid | | The region of a mitochondrion to which the DNA is confined. |
| | GO:0005739 | | mitochondrion | | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
| | GO:0000784 | | nuclear chromosome, telomeric region | | The terminal region of a linear nuclear chromosome that includes the telomeric DNA repeats and associated proteins. |
| | GO:0000783 | | nuclear telomere cap complex | | A complex of DNA and protein located at the end of a linear chromosome in the nucleus that protects and stabilizes a linear chromosome. |
| | GO:0005730 | | nucleolus | | A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome. |
| | GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0000333 | | telomerase catalytic core complex | | The minimal catalytic core of telomerase is a ribonucleoprotein complex composed of a catalytic reverse transcriptase subunit and an RNA subunit that provides the template for telomeric DNA addition. |
| | GO:0005697 | | telomerase holoenzyme complex | | Telomerase is a ribonucleoprotein enzyme complex, with a minimal catalytic core composed of a catalytic reverse transcriptase subunit and an RNA subunit that provides the template for telomeric DNA addition. In vivo, the holoenzyme complex often contains additional subunits. |
|
Description
